Issue 28, 2006

Fullerene (C60) immunoconjugates: interaction of water-soluble C60 derivatives with the murine anti-gp240 melanoma antibody

Abstract

The first fullerene (C60) immunoconjugates have been prepared and characterized as an initial step toward the development of fullerene immunotherapy (FIT).

Graphical abstract: Fullerene (C60) immunoconjugates: interaction of water-soluble C60 derivatives with the murine anti-gp240 melanoma antibody

Supplementary files

Article information

Article type
Communication
Submitted
07 Feb 2006
Accepted
08 May 2006
First published
09 Jun 2006

Chem. Commun., 2006, 3004-3006

Fullerene (C60) immunoconjugates: interaction of water-soluble C60 derivatives with the murine anti-gp240 melanoma antibody

J. M. Ashcroft, D. A. Tsyboulski, K. B. Hartman, T. Y. Zakharian, J. W. Marks, R. B. Weisman, M. G. Rosenblum and L. J. Wilson, Chem. Commun., 2006, 3004 DOI: 10.1039/B601717G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements